These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 3892073)

  • 1. Disease-specific amino acid infusion (F080) in hepatic encephalopathy: a prospective, randomized, double-blind, controlled trial.
    Cerra FB; Cheung NK; Fischer JE; Kaplowitz N; Schiff ER; Dienstag JL; Bower RH; Mabry CD; Leevy CM; Kiernan T
    JPEN J Parenter Enteral Nutr; 1985; 9(3):288-95. PubMed ID: 3892073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cirrhosis, encephalopathy, and improved results with metabolic support.
    Cerra FB; McMillen M; Angelico R; Cline B; Lyons J; Faulkenbach L; Paysinger J
    Surgery; 1983 Oct; 94(4):612-9. PubMed ID: 6623361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total parenteral nutrition with F080 in cirrhotics with subclinical encephalopathy.
    Millikan WJ; Henderson JM; Warren WD; Riepe SP; Kutner MH; Wright-Bacon L; Epstein C; Parks RB
    Ann Surg; 1983 Mar; 197(3):294-304. PubMed ID: 6402994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind randomized clinical trial comparing neomycin and placebo in the treatment of exogenous hepatic encephalopathy.
    Strauss E; Tramote R; Silva EP; Caly WR; Honain NZ; Maffei RA; de Sá MF
    Hepatogastroenterology; 1992 Dec; 39(6):542-5. PubMed ID: 1483668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disease-specific amino acid infusion (F080) in hepatic encephalopathy.
    Cerra FB
    JPEN J Parenter Enteral Nutr; 1987; 11(1):107-8. PubMed ID: 3820517
    [No Abstract]   [Full Text] [Related]  

  • 6. Infusion of branched-chain enriched amino acid solution in patients with hepatic encephalopathy.
    Freund H; Dienstag J; Lehrich J; Yoshimura N; Bradford RR; Rosen H; Atamian S; Slemmer E; Holroyde J; Fischer JE
    Ann Surg; 1982 Aug; 196(2):209-20. PubMed ID: 6284073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term oral branched-chain amino acid treatment in chronic hepatic encephalopathy. A randomized double-blind casein-controlled trial. The Italian Multicenter Study Group.
    Marchesini G; Dioguardi FS; Bianchi GP; Zoli M; Bellati G; Roffi L; Martines D; Abbiati R
    J Hepatol; 1990 Jul; 11(1):92-101. PubMed ID: 2204661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Branched chain enriched amino acid versus glucose treatment of hepatic encephalopathy. A double-blind study of 65 patients with cirrhosis.
    Vilstrup H; Gluud C; Hardt F; Kristensen M; Køhler O; Melgaard B; Dejgaard A; Hansen BA; Krintel JJ; Schütten HJ
    J Hepatol; 1990 May; 10(3):291-6. PubMed ID: 2195106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Branched-chain amino acid-enriched elemental diet in patients with cirrhosis of the liver. A double blind crossover trial.
    Sieg A; Walker S; Czygan P; Gärtner U; Lanzinger-Rossnagel G; Stiehl A; Kommerell B
    Z Gastroenterol; 1983 Nov; 21(11):644-50. PubMed ID: 6362243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lactulose-neomycin combination versus placebo in the treatment of acute hepatic encephalopathy. Results of a randomized controlled trial].
    Blanc P; Daurès JP; Liautard J; Buttigieg R; Desprez D; Pageaux G; Allaz JL; Parelon G; Larrey D; Michel H
    Gastroenterol Clin Biol; 1994; 18(12):1063-8. PubMed ID: 7750678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of chronic portal--systemic encephalopathy with vegetable and animal protein diets. A controlled crossover study.
    Uribe M; Márquez MA; Garcia Ramos G; Ramos-Uribe MH; Vargas F; Villalobos A; Ramos C
    Dig Dis Sci; 1982 Dec; 27(12):1109-16. PubMed ID: 6756833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease-specific amino acid infusion (F080) in hepatic encephalopathy: a prospective, randomized, double-blind, controlled trial.
    Cowan GS
    JPEN J Parenter Enteral Nutr; 1986; 10(2):247. PubMed ID: 3514982
    [No Abstract]   [Full Text] [Related]  

  • 13. Rifaximin versus neomycin on hyperammoniemia in chronic portal systemic encephalopathy of cirrhotics. A double-blind, randomized trial.
    Pedretti G; Calzetti C; Missale G; Fiaccadori F
    Ital J Gastroenterol; 1991 May; 23(4):175-8. PubMed ID: 1751811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is intravenous administration of branched chain amino acids effective in the treatment of hepatic encephalopathy? A multicenter study.
    Wahren J; Denis J; Desurmont P; Eriksson LS; Escoffier JM; Gauthier AP; Hagenfeldt L; Michel H; Opolon P; Paris JC; Veyrac M
    Hepatology; 1983; 3(4):475-80. PubMed ID: 6345330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The dietary protein contribution and hepatic encephalopathy in cirrhosis].
    Zavaglia C; Brivio M; Losacco E; Onida L
    Recenti Prog Med; 1992 Apr; 83(4):218-23. PubMed ID: 1626117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flumazenil in cirrhotic patients in hepatic coma: a randomized double-blind placebo-controlled crossover trial.
    Pomier-Layrargues G; Giguère JF; Lavoie J; Perney P; Gagnon S; D'Amour M; Wells J; Butterworth RF
    Hepatology; 1994 Jan; 19(1):32-7. PubMed ID: 8276366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of preventive effect of branched-chain amino acid solution on postoperative hepatic encephalopathy in patients with cirrhosis: a randomized, prospective trial.
    Kanematsu T; Koyanagi N; Matsumata T; Kitano S; Takenaka K; Sugimachi K
    Surgery; 1988 Sep; 104(3):482-8. PubMed ID: 2842882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enteral and parenteral branched chain amino acid-supplemented nutritional support in patients with encephalopathy due to alcoholic liver disease.
    O'Keefe SJ; Ogden J; Dicker J
    JPEN J Parenter Enteral Nutr; 1987; 11(5):447-53. PubMed ID: 3116290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study.
    Kircheis G; Nilius R; Held C; Berndt H; Buchner M; Görtelmeyer R; Hendricks R; Krüger B; Kuklinski B; Meister H; Otto HJ; Rink C; Rösch W; Stauch S
    Hepatology; 1997 Jun; 25(6):1351-60. PubMed ID: 9185752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial.
    Conn HO; Leevy CM; Vlahcevic ZR; Rodgers JB; Maddrey WC; Seeff L; Levy LL
    Gastroenterology; 1977 Apr; 72(4 Pt 1):573-83. PubMed ID: 14049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.